Literature DB >> 29556152

Atrial Septal Defect as Unexpected Cause of Pulmonary Artery Hypertension.

Rushi V Parikh, Jack Boyd, David P Lee, Ronald Witteles.   

Abstract

Methamphetamine abuse is an increasingly prevalent cause of pulmonary artery hypertension in the United States. Conversely, an atrial septal defect rarely presents late as pulmonary artery hypertension. We present the case of a 44-year-old methamphetamine abuser who had a 3-month history of worsening fatigue and near-syncope. She had elevated cardiac enzyme levels and right-sided heart strain. Angiographic findings suggested methamphetamine-induced pulmonary artery hypertension; however, we later heard S2 irregularities that raised suspicion of an atrial septal defect. Ultimately, the diagnosis was pulmonary artery hypertension and a large secundum atrial septal defect with left-to-right flow. One year after defect closure, the patient was asymptomatic. In addition to discussing this unexpected case of a secundum atrial septal defect masquerading as methamphetamine-induced pulmonary artery hypertension, we briefly review the natural history of atrial septal defects and emphasize the importance of thorough examination in avoiding diagnostic anchoring bias.

Entities:  

Keywords:  Diagnosis, differential; drug-related side effects and adverse reactions/etiology/physiopathology; female; heart septal defects, atrial/complications/surgery; hypertension, pulmonary/chemically induced/diagnosis/epidemiology; treatment outcome; ventricular dysfunction, right/complications

Mesh:

Year:  2018        PMID: 29556152      PMCID: PMC5832086          DOI: 10.14503/THIJ-17-6208

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  9 in total

Review 1.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.

Authors:  Denise van der Linde; Elisabeth E M Konings; Maarten A Slager; Maarten Witsenburg; Willem A Helbing; Johanna J M Takkenberg; Jolien W Roos-Hesselink
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

Review 2.  Drug-induced pulmonary arterial hypertension: a recent outbreak.

Authors:  David Montani; Andrei Seferian; Laurent Savale; Gérald Simonneau; Marc Humbert
Journal:  Eur Respir Rev       Date:  2013-09-01

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Authors:  Kelly M Chin; Richard N Channick; Lewis J Rubin
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

5.  ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease).

Authors:  Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb
Journal:  Circulation       Date:  2008-11-07       Impact factor: 29.690

6.  Natural history of atrial septal defect.

Authors:  M Campbell
Journal:  Br Heart J       Date:  1970-11

7.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

8.  Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction.

Authors:  P M Steele; V Fuster; M Cohen; D G Ritter; D C McGoon
Journal:  Circulation       Date:  1987-11       Impact factor: 29.690

9.  A comparison of surgical and medical therapy for atrial septal defect in adults.

Authors:  S Konstantinides; A Geibel; M Olschewski; L Görnandt; H Roskamm; G Spillner; H Just; W Kasper
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.